In this episode of the Research Forward podcast, we interview Sergio Salazar, a veterinarian, biomedical consultant and the co-founder of Ovum SPF, a startup revolutionizing vaccine production using specified pathogen-free (SPF) eggs. The discussion delves into Sergio's background, his journey from veterinary medicine to biomedical consulting, and his experiences working in various countries.

The conversation highlights the critical role of SPF eggs in vaccine development, especially in light of the COVID-19 pandemic. Sergio explains how Ovum SPF's new facility in Cascante, Navarra, Spain, is designed with advanced biosecurity measures to ensure the highest quality and cleanliness of the eggs. This facility represents a significant step forward in biomedicine and public health, aiming to meet the growing demand for robust and responsive vaccine production.

Sergio also discusses the challenges and successes in setting up the facility, including significant investments and public funding support from entities like SODENA. The episode touches on the broader economic and social impact of Ovum SPF on the local community and the biotechnology sector, emphasizing the company's commitment to sustainability and local collaboration.

Looking ahead, Sergio shares Ovum SPF's future plans, including potential expansions and contributions to pandemic preparedness. The episode concludes with insights into how Ovum SPF aims to provide a valuable option for vaccine production, alongside recombinant and cell-based technologies, and its potential applications beyond vaccines in biomedicine and animal health.